Advisory and consulting services
Native Alpha™ Advisory
Native Alpha™ advisory and consulting services help senior executives, founders, and investors find the unusual advantage already inside a company, asset, or market position, and decide what to build, buy, fund, or stop doing because of it.
The core principle
Moving to AI without knowing your native alpha compounds the mistake
Every life sciences and healthtech leader I talk to is under the same pressure. The board asks for the AI roadmap. A competitor announces something. An investor asks why you aren’t moving faster. The urgency is real, and it’s reasonable to want to move.
Moving to AI is not the mistake. Moving to AI without knowing what only your company can do is. Without that knowledge, you point AI at commodity work, buy the same tools every rival can buy, and automate the parts anyone can automate. The spending feels like progress, and every quarter of it compounds the problem: more vendor dependence, more sameness, less that is actually yours.
In life sciences this shows up as pilots on the same public models everyone else runs, while the real assets sit untouched: the clinical data, the regulatory position, the relationships with investigators, sites, and payers. Those are the things a competitor cannot rent by next quarter.
AI is an amplifier. It makes your native advantage stronger when you know what it is. It makes your commodity position more replaceable when you don’t. That’s why the fastest movers run the native alpha analysis first, then aim their AI spending at the advantage. Same speed, very different outcome.
Engagements offered under Native Alpha™ Advisory
Native Alpha™ Discovery
A structured engagement to surface and prioritize a company’s native advantages.
Bring me in when
- Your roadmap looks like every competitor’s roadmap.
- You’re about to raise, acquire, or spend big on AI and can’t say what only you can do.
- A new CEO, board, or owner wants an honest read before setting strategy.
- You’re in life sciences or healthtech, and AI budgets are about to land on work any competitor could match.
What the work covers
- Interviews with leadership, customers, and the people who do the actual work.
- A look at your data, workflows, regulatory position, and relationships that a rival can’t buy or copy quickly.
- Each candidate advantage gets tested: is it unusual, does someone outside the room pay for it, and how long will it last?
- What you get
- A ranked list of your native advantages, the evidence behind each one, and a decision ledger of what to build, buy, fund, or stop because of them.
- Format
- Fixed scope, usually four to six weeks.
Native Alpha™ Strategy Consulting
Business and management consulting to identify and allocate asymmetric advantage before capital is committed.
Bring me in when
- You’re weighing build versus buy versus partner on something expensive.
- An acquisition, carve-out, or new product line needs a technology and advantage review.
- Engineering is busy, but you can’t tell which of the work makes you harder to replace.
What the work covers
- Capital allocation reviews that separate spending on your advantage from spending on commodity work.
- Technology and AI strategy built around what you already own, not what a vendor is selling this quarter.
- Due diligence for investors and acquirers on whether a target’s claimed edge is real.
- Life sciences and healthtech reviews: which parts of your clinical, regulatory, or data position are genuinely hard to copy, and which parts a vendor can rent to anyone.
- New venture, product, and business model design that starts from your advantage.
- What you get
- A written strategy with the investment case, the options you’re not taking and why, milestones, and the signals that should make you change course.
- Format
- Project based, scoped to the decision, typically two to four months.
Native Alpha™ Executive Advisory
Ongoing advisory for leadership teams on strategy, decision-making, and capital allocation.
Bring me in when
- You want a senior technology and venture voice on call without hiring a full-time executive.
- Your board or leadership team keeps making big bets without someone who’s built and sold companies in the room.
- You’ve done the Discovery work and want help keeping decisions tied to it.
What the work covers
- Regular working sessions with the CEO, founders, or leadership team.
- Review of major spending, vendor, hiring, and partnership decisions before they’re signed.
- Board and investor preparation, including how to explain your advantage in plain terms.
- Quarterly check on whether your advantage is growing, holding, or wearing away.
- What you get
- Fewer expensive surprises, faster decisions, and a leadership team that can say in one sentence why customers pick you.
- Format
- Monthly retainer, usually six months or longer, fractional CTO or CTVO roles available.
Who these engagements are for
- CEOs and founders deciding where the next dollar and the next year of engineering should go.
- Boards who want an independent read on technology strategy and AI spending.
- Private equity and venture investors testing whether a company’s edge is real before or after they buy.
- Leaders of regulated businesses in healthcare, medical devices, life sciences, and government, where advantage often hides in compliance and data.
- Life sciences and healthtech executives under pressure to show an AI story before they spend millions on the wrong part of it.
Most clients start with Discovery. Some go straight to Strategy Consulting when a specific decision is already on the table. Executive Advisory works best once we both know what the advantage is.
Engagements are delivered by Shahid N. Shah.
Want the thinking behind the work first? Read The Native Alpha™ Series.